Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance

Margaret L. Dahn, Brianne M. Cruickshank, Ainsleigh J. Jackson, Cheryl Dean, Ryan W. Holloway, Steven R. Hall, Krysta M. Coyle, Hillary Maillet, David M. Waisman, Kerry B. Goralski, Carman A. Giacomantonio, Ian C.G. Weaver, Paola Marcato

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)
Original languageEnglish
Pages (from-to)1110-1122
Number of pages13
JournalMolecular Cancer Therapeutics
Volume19
Issue number5
DOIs
Publication statusPublished - May 1 2020

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance'. Together they form a unique fingerprint.

Cite this